This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Min, J. Articles by Alexander, S. Search for Related Content PubMed PubMed Citation Articles by Min, J. Articles by Alexander, S.

 Previous Article  |  Next Article 

Eukaryotic Cell, January 2005, p. 178-189, Vol. 4, No. 1
1535-9778/05/$08.00+0     doi:10.1128/EC.4.1.178-189.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Sphingosine Kinase Regulates the Sensitivity of Dictyostelium discoideum Cells to the Anticancer Drug Cisplatin

Division of Biological Sciences, University of Missouri, Columbia, Missouri,¹ MRC Laboratory of Molecular Biology, Cambridge, United Kingdom,² Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma³

Received 26 August 2004/ Accepted 13 October 2004

The drug cisplatin is widely used to treat a number of tumor types. However, resistance to the drug, which remains poorly understood, limits its usefulness. Previous work using Dictyostelium discoideum as a model for studying drug resistance showed that mutants lacking sphingosine-1-phosphate (S-1-P) lyase, the enzyme that degrades S-1-P, had increased resistance to cisplatin, whereas mutants overexpressing the enzyme were more sensitive to the drug. S-1-P is synthesized from sphingosine and ATP by the enzyme sphingosine kinase. We have identified two sphingosine kinase genes in D. discoideum—sgkA and sgkB—that are homologous to those of other species. The biochemical properties of the SgkA and SgkB enzymes suggest that they are the equivalent of the human Sphk1 and Sphk2 enzymes, respectively. Disruption of the kinases by homologous recombination (both single and double mutants) or overexpression of the sgkA gene resulted in altered growth rates and altered response to cisplatin. The null mutants showed increased sensitivity to cisplatin, whereas mutants overexpressing the sphingosine kinase resulted in increased resistance compared to the parental cells. The results indicate that both the SgkA and the SgkB enzymes function in regulating cisplatin sensitivity. The increase in sensitivity of the sphingosine kinase-null mutants was reversed by the addition of S-1-P, and the increased resistance of the sphingosine kinase overexpressor mutant was reversed by the inhibitor N,N-dimethylsphingosine. Parallel changes in sensitivity of the null mutants are seen with the platinum-based drug carboplatin but not with doxorubicin, 5-fluorouracil, and etoposide. This pattern of specificity is similar to that observed with the S-1-P lyase mutants and should be useful in designing therapeutic schemes involving more than one drug. This study identifies the sphingosine kinases as new drug targets for modulating the sensitivity to platinum-based drugs.

This article has been cited by other articles:

• Van Driessche, N., Alexander, H., Min, J., Kuspa, A., Alexander, S., Shaulsky, G. (2007). Global transcriptional responses to cisplatin in Dictyostelium discoideum identify potential drug targets. Proc. Natl. Acad. Sci. USA 104: 15406-15411 [Abstract] [Full Text]  
• Min, J., Mesika, A., Sivaguru, M., Van Veldhoven, P. P., Alexander, H., Futerman, A. H., Alexander, S. (2007). (Dihydro)ceramide Synthase 1 Regulated Sensitivity to Cisplatin Is Associated with the Activation of p38 Mitogen-Activated Protein Kinase and Is Abrogated by Sphingosine Kinase 1. Mol Cancer Res 5: 801-812 [Abstract] [Full Text]  
• Chisholm, R. L., Gaudet, P., Just, E. M., Pilcher, K. E., Fey, P., Merchant, S. N., Kibbe, W. A. (2006). dictyBase, the model organism database for Dictyostelium discoideum. Nucleic Acids Res 34: D423-D427 [Abstract] [Full Text]  
• Chalfant, C. E., Spiegel, S. (2005). Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J. Cell Sci. 118: 4605-4612 [Abstract] [Full Text]  
• Min, J., Van Veldhoven, P. P., Zhang, L., Hanigan, M. H., Alexander, H., Alexander, S. (2005). Sphingosine-1-Phosphate Lyase Regulates Sensitivity of Human Cells to Select Chemotherapy Drugs in a p38-Dependent Manner. Mol Cancer Res 3: 287-296 [Abstract] [Full Text]